NCT01648192View on ClinicalTrials.gov

Phase I Study of GW856553 (Losmapimod)

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 24, 2012

Primary Completion Date

October 26, 2012

Study Completion Date

October 26, 2012

Conditions

Acute Coronary Syndrome

Interventions

DRUG

Losmapimod for single dose

Film coated white tablet

DRUG

Losmapimod for repeat dose

Film coated white tablet

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01648192 - Phase I Study of GW856553 (Losmapimod) | Biotech Hunter | Biotech Hunter